Open AccessS263: PHASE I OPEN‐LABEL SINGLE ARM STUDY OF GPRC5D CAR‐T CELLS (ORICAR‐017) IN PATIENTS WITH RELAPTSED/REFRACTORY MULTIPLE MYELOMA (POLARIS)
Author(s) -
Zhang M.,
Hu Y.,
Ding X.,
Tang Y.,
Yang Y.,
Chen S.,
Huang H.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843944.17251.d4
Subject(s) - medicine , tolerability , fludarabine , refractory (planetary science) , gastroenterology , multiple myeloma , regimen , pharmacokinetics , cyclophosphamide , surgery , oncology , chemotherapy , adverse effect , physics , astrobiology